333 related articles for article (PubMed ID: 34432196)
1. Assessing the Impact of Colchicine on Coronary Plaque Phenotype After Myocardial Infarction with Optical Coherence Tomography: Rationale and Design of the COCOMO-ACS Study.
Montarello NJ; Singh K; Sinhal A; Wong DTL; Alcock R; Rajendran S; Dautov R; Barlis P; Patel S; Nidorf SM; Thompson PL; Salagaras T; Butters J; Nerlekar N; Di Giovanni G; Ottaway JL; Nicholls SJ; Psaltis PJ
Cardiovasc Drugs Ther; 2022 Dec; 36(6):1175-1186. PubMed ID: 34432196
[TBL] [Abstract][Full Text] [Related]
2. Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trial.
Zanchin C; Koskinas KC; Ueki Y; Losdat S; Häner JD; Bär S; Otsuka T; Inderkum A; Jensen MRJ; Lonborg J; Fahrni G; Ondracek AS; Daemen J; van Geuns RJ; Iglesias JF; Matter CM; Spirk D; Juni P; Mach F; Heg D; Engstrom T; Lang I; Windecker S; Räber L
Am Heart J; 2021 Aug; 238():33-44. PubMed ID: 33951415
[TBL] [Abstract][Full Text] [Related]
3. Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.
Räber L; Ueki Y; Otsuka T; Losdat S; Häner JD; Lonborg J; Fahrni G; Iglesias JF; van Geuns RJ; Ondracek AS; Radu Juul Jensen MD; Zanchin C; Stortecky S; Spirk D; Siontis GCM; Saleh L; Matter CM; Daemen J; Mach F; Heg D; Windecker S; Engstrøm T; Lang IM; Koskinas KC;
JAMA; 2022 May; 327(18):1771-1781. PubMed ID: 35368058
[TBL] [Abstract][Full Text] [Related]
4. Impact of PCSK9 inhibitors on coronary atheroma phenotype following myocardial infarction: insights from intravascular imaging.
Abrahams T; Fujino M; Nelson AJ; Nicholls SJ
Curr Opin Cardiol; 2023 Nov; 38(6):504-508. PubMed ID: 37751373
[TBL] [Abstract][Full Text] [Related]
5. Effects of statins on plaque rupture assessed by optical coherence tomography in patients presenting with acute coronary syndromes: insights from the optical coherence tomography (OCT)-FORMIDABLE registry.
Gili S; Iannaccone M; Colombo F; Montefusco A; Amabile N; Calcagno S; Capodanno D; Scalone G; Rognoni A; Omedè P; Ugo F; Cavallo E; Mancone M; Mangiameli A; Boccuzzi G; Hiansen J; Motreff P; Toutouzas K; Garbo R; Sardella G; Tamburino C; D'Amico M; Moretti C; Templin C; Gaita F; Souteyrand G; Niccoli G; D'Ascenzo F
Eur Heart J Cardiovasc Imaging; 2018 May; 19(5):524-531. PubMed ID: 28605473
[TBL] [Abstract][Full Text] [Related]
6. Healed Culprit Plaques in Patients With Acute Coronary Syndromes.
Fracassi F; Crea F; Sugiyama T; Yamamoto E; Uemura S; Vergallo R; Porto I; Lee H; Fujimoto J; Fuster V; Jang IK
J Am Coll Cardiol; 2019 May; 73(18):2253-2263. PubMed ID: 31072568
[TBL] [Abstract][Full Text] [Related]
7. Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study.
Nicholls SJ; Nissen SE; Prati F; Windecker S; Kataoka Y; Puri R; Hucko T; Kassahun H; Liao J; Somaratne R; Butters J; Di Giovanni G; Jones S; Psaltis PJ
Cardiovasc Diagn Ther; 2021 Feb; 11(1):120-129. PubMed ID: 33708484
[TBL] [Abstract][Full Text] [Related]
8. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS.
Hattori K; Ozaki Y; Ismail TF; Okumura M; Naruse H; Kan S; Ishikawa M; Kawai T; Ohta M; Kawai H; Hashimoto T; Takagi Y; Ishii J; Serruys PW; Narula J
JACC Cardiovasc Imaging; 2012 Feb; 5(2):169-77. PubMed ID: 22340823
[TBL] [Abstract][Full Text] [Related]
9. Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction.
Nicholls SJ; Kataoka Y; Nissen SE; Prati F; Windecker S; Puri R; Hucko T; Aradi D; Herrman JR; Hermanides RS; Wang B; Wang H; Butters J; Di Giovanni G; Jones S; Pompili G; Psaltis PJ
JACC Cardiovasc Imaging; 2022 Jul; 15(7):1308-1321. PubMed ID: 35431172
[TBL] [Abstract][Full Text] [Related]
10. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography.
Jia H; Abtahian F; Aguirre AD; Lee S; Chia S; Lowe H; Kato K; Yonetsu T; Vergallo R; Hu S; Tian J; Lee H; Park SJ; Jang YS; Raffel OC; Mizuno K; Uemura S; Itoh T; Kakuta T; Choi SY; Dauerman HL; Prasad A; Toma C; McNulty I; Zhang S; Yu B; Fuster V; Narula J; Virmani R; Jang IK
J Am Coll Cardiol; 2013 Nov; 62(19):1748-58. PubMed ID: 23810884
[TBL] [Abstract][Full Text] [Related]
11. Changes in Coronary Plaque Composition in Patients With Acute Myocardial Infarction Treated With High-Intensity Statin Therapy (IBIS-4): A Serial Optical Coherence Tomography Study.
Räber L; Koskinas KC; Yamaji K; Taniwaki M; Roffi M; Holmvang L; Garcia Garcia HM; Zanchin T; Maldonado R; Moschovitis A; Pedrazzini G; Zaugg S; Dijkstra J; Matter CM; Serruys PW; Lüscher TF; Kelbaek H; Karagiannis A; Radu MD; Windecker S
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 1):1518-1528. PubMed ID: 30553686
[TBL] [Abstract][Full Text] [Related]
12. Frequency, Predictors, Distribution, and Morphological Characteristics of Layered Culprit and Nonculprit Plaques of Patients With Acute Myocardial Infarction: In Vivo 3-Vessel Optical Coherence Tomography Study.
Dai J; Fang C; Zhang S; Li L; Wang Y; Xing L; Yu H; Jiang S; Yin Y; Wang J; Wang Y; Guo J; Lei F; Liu H; Xu M; Ren X; Ma L; Wei G; Zhang S; Hou J; Mintz GS; Yu B
Circ Cardiovasc Interv; 2020 Oct; 13(10):e009125. PubMed ID: 32957793
[TBL] [Abstract][Full Text] [Related]
13. Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy.
Rexhaj E; Bär S; Soria R; Ueki Y; Häner JD; Otsuka T; Kavaliauskaite R; Siontis GC; Stortecky S; Shibutani H; Spirk D; Engstrøm T; Lang I; Morf L; Ambühl M; Windecker S; Losdat S; Koskinas KC; Räber L;
Atherosclerosis; 2024 May; 392():117504. PubMed ID: 38513436
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of non-culprit plaques in acute coronary syndrome patients with layered culprit plaque.
Russo M; Kim HO; Kurihara O; Araki M; Shinohara H; Thondapu V; Yonetsu T; Soeda T; Minami Y; Higuma T; Lee H; Fracassi F; Vergallo R; Niccoli G; Crea F; Fuster V; Jang IK
Eur Heart J Cardiovasc Imaging; 2020 Dec; 21(12):1421-1430. PubMed ID: 31848590
[TBL] [Abstract][Full Text] [Related]
15. Concomitant Coronary Atheroma Regression and Stabilization in Response to Lipid-Lowering Therapy.
Biccirè FG; Häner J; Losdat S; Ueki Y; Shibutani H; Otsuka T; Kakizaki R; Hofbauer TM; van Geuns RJ; Stortecky S; Siontis GCM; Bär S; Lønborg J; Heg D; Kaiser C; Spirk D; Daemen J; Iglesias JF; Windecker S; Engstrøm T; Lang I; Koskinas KC; Räber L
J Am Coll Cardiol; 2023 Oct; 82(18):1737-1747. PubMed ID: 37640248
[TBL] [Abstract][Full Text] [Related]
16. Low Plasma Adiponectin Levels Are Associated With Vulnerable Plaque Features in Patients With Acute Coronary Syndrome: An Optical Coherence Tomography Study.
Refaat H; Tantawy A
Cardiovasc Revasc Med; 2021 Apr; 25():63-71. PubMed ID: 33097459
[TBL] [Abstract][Full Text] [Related]
17. Effect of evolocumab therapy on coronary fibrous cap thickness assessed by optical coherence tomography in patients with acute coronary syndrome.
Yano H; Horinaka S; Ishimitsu T
J Cardiol; 2020 Mar; 75(3):289-295. PubMed ID: 31495548
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Myocardial Infarction in Patients With Nonobstructive Coronary Artery Disease: Results From the Optical Coherence Tomography Study.
Opolski MP; Spiewak M; Marczak M; Debski A; Knaapen P; Schumacher SP; Staruch AD; Grodecki K; Chmielak Z; Lazarczyk H; Kukula K; Tyczynski P; Pregowski J; Dabrowski M; Kadziela J; Florczak E; Skrobisz A; Witkowski A
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 1):2210-2221. PubMed ID: 30343070
[TBL] [Abstract][Full Text] [Related]
19. Culprit plaque characteristics in women vs men with a first ST-segment elevation myocardial infarction: In vivo optical coherence tomography insights.
Sun R; Sun L; Fu Y; Liu H; Xu M; Ren X; Yu H; Dong H; Liu Y; Zhu Y; Tian J; Yu B
Clin Cardiol; 2017 Dec; 40(12):1285-1290. PubMed ID: 29247510
[TBL] [Abstract][Full Text] [Related]
20. Differential immunological signature at the culprit site distinguishes acute coronary syndrome with intact from acute coronary syndrome with ruptured fibrous cap: results from the prospective translational OPTICO-ACS study.
Leistner DM; Kränkel N; Meteva D; Abdelwahed YS; Seppelt C; Stähli BE; Rai H; Skurk C; Lauten A; Mochmann HC; Fröhlich G; Rauch-Kröhnert U; Flores E; Riedel M; Sieronski L; Kia S; Strässler E; Haghikia A; Dirks F; Steiner JK; Mueller DN; Volk HD; Klotsche J; Joner M; Libby P; Landmesser U
Eur Heart J; 2020 Oct; 41(37):3549-3560. PubMed ID: 33080003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
